Literature DB >> 17390145

Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years.

Jiun-Ho Ju1, Shih-Ching Chang, Huann-Shen Wang, Shung-Haur Yang, Jen-Kae Jiang, Wei-Chone Chen, Tzu-Chen Lin, Feng-Ming Wang, Jen-Kou Lin.   

Abstract

BACKGROUND AND AIMS: Colorectal cancer (CRC) is the third most common cause of cancer-related death in Taiwan. During the past 20 years, several advances have improved the treatment outcome and quality of life of CRC patients. The purpose of this study was to identify the changes in the clinicopathological features and outcome of CRC over this period.
MATERIALS AND METHODS: Based on the computerized database of the Taipei Veterans General Hospital, between January 1981 and December 2000, 5,474 CRC patients were identified and divided into 2 groups based on the date of treatment (1981-1990 and 1991-2000). The clinicopathological features, outcome, and prognostic factors were analyzed and compared. RESULTS/
FINDINGS: The age at onset of cancer was 61 years in the 1980s group and 66 years in the 1990s group. The frequency of rectal tumors decreased from 50% in the 1980s group to 44% in the 1990s group. Tumor, nodes, metastasis (TNM) stage distribution, surgical mortality, and anastomosis leakage were similar in the two groups. However, the 5-year overall survival rate was better in the 1990s group (56%) than that in the 1980s group (50%, P = 0.001). For rectal cancer patients, the local recurrence rate was lower in the 1990s group (6%) than that in the 1980s group (10%, P < 0.01). In stage III CRC, the 5-year overall survival rate was significantly higher in the 1990s group (54%) than that in the 1980s group (48%, P = 0.011). TNM stage was the most important independent prognostic factor for overall and disease-free survivals, followed by differentiation grade, CEA level, and treatment period. INTERPRETATION/
CONCLUSION: Advances in surgical technique and more standard use of chemotherapy have improved CRC outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17390145     DOI: 10.1007/s00384-007-0293-z

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.796


  41 in total

1.  Colorectal carcinoma in patients less than 40 years old.

Authors:  N L Simstein; P J Kovalcik; G H Cross
Journal:  Dis Colon Rectum       Date:  1978-04       Impact factor: 4.585

2.  Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule.

Authors:  Eric Rullier; Christophe Laurent; Frédéric Bretagnol; Anne Rullier; Véronique Vendrely; Frank Zerbib
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

3.  Surgeon-related factors and outcome in rectal cancer.

Authors:  G A Porter; C L Soskolne; W W Yakimets; S C Newman
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

Review 4.  Epidermal growth factor receptor-targeted therapy in colorectal cancer.

Authors:  Peter J O'dwyer; Al B Benson
Journal:  Semin Oncol       Date:  2002-10       Impact factor: 4.929

Review 5.  Colorectal cancer.

Authors:  Jürgen Weitz; Moritz Koch; Jürgen Debus; Thomas Höhler; Peter R Galle; Markus W Büchler
Journal:  Lancet       Date:  2005 Jan 8-14       Impact factor: 79.321

6.  Evidence of the effect of 'specialization' on the management, surgical outcome and survival from colorectal cancer in Wessex.

Authors:  J A E Smith; P M King; R H S Lane; M R Thompson
Journal:  Br J Surg       Date:  2003-05       Impact factor: 6.939

7.  Colon cancer in France: evidence for improvement in management and survival.

Authors:  C Faivre-Finn; A-M Bouvier-Benhamiche; J M Phelip; S Manfredi; V Dancourt; J Faivre
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

8.  A case-control study of screening sigmoidoscopy and mortality from colorectal cancer.

Authors:  J V Selby; G D Friedman; C P Quesenberry; N S Weiss
Journal:  N Engl J Med       Date:  1992-03-05       Impact factor: 91.245

9.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

Authors:  C G Moertel; T R Fleming; J S Macdonald; D G Haller; J A Laurie; P J Goodman; J S Ungerleider; W A Emerson; D C Tormey; J H Glick
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

10.  Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer.

Authors:  T R Buroker; M J O'Connell; H S Wieand; J E Krook; J B Gerstner; J A Mailliard; P L Schaefer; R Levitt; C G Kardinal; D H Gesme
Journal:  J Clin Oncol       Date:  1994-01       Impact factor: 44.544

View more
  19 in total

1.  Higher parity and earlier age at first birth are associated with lower risk of death from colon cancer.

Authors:  Chao-Hung Kuo; Chien-Chun Kuo; Hsiu-Yi Wu; Deng-Chyang Wu; Chun-Yuh Yang
Journal:  Cancer Sci       Date:  2012-07-04       Impact factor: 6.716

2.  Can horizontal diameter of colorectal tumor help predict prognosis?

Authors:  Ahmet Ziya Balta; Yavuz Özdemir; İlker Sücüllü; Serhat Tolga Derici; Mahir Bağcı; Dilaver Demirel; Mehmet Levhi Akın
Journal:  Ulus Cerrahi Derg       Date:  2014-09-01

3.  The role of adjuvant chemotherapy in stage II colorectal cancer patients.

Authors:  Hung-Hsin Lin; Yu-Yao Chang; Jen-Kou Lin; Jeng-Kai Jiang; Chun-Chi Lin; Yuan-Tzu Lan; Shung-Haur Yang; Huann-Sheng Wang; Wei-Shone Chen; Tzu-Chen Lin; Shih-Ching Chang
Journal:  Int J Colorectal Dis       Date:  2014-07-15       Impact factor: 2.571

4.  Human cervical cancer oncogene-1 over expression in colon cancer and its clinical significance.

Authors:  Kai Meng; Min Yuan; Shujian Xu; Lifeng Wang; Zhe Li; Mingyu Wang; Rong Ma
Journal:  Int J Clin Exp Med       Date:  2015-01-15

5.  Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute.

Authors:  Chun-Chi Lin; Jen-Kou Lin; Shih-Ching Chang; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Wei-Shone Chen; Tzu-Chen Lin
Journal:  Int J Colorectal Dis       Date:  2009-02-24       Impact factor: 2.571

6.  High concordance of mutation patterns in 10 common mutated genes between tumor tissue and cell-free DNA in metastatic colorectal cancer.

Authors:  Yuan-Tzu Lan; Shih-Ching Chang; Pei-Ching Lin; Chien-Hsing Lin; Wen-Yi Liang; Wei-Shone Chen; Jeng-Kai Jiang; Shung-Haur Yang; Jen-Kou Lin
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

7.  Diabetes but not insulin is associated with higher colon cancer mortality.

Authors:  Chin-Hsiao Tseng
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

8.  HLA-A2 expression, stage, and survival in colorectal cancer.

Authors:  Philipp Kiewe; Veit Mansmann; Carmen Scheibenbogen; Heinz-Johannes Buhr; Eckhard Thiel; Dirk Nagorsen
Journal:  Int J Colorectal Dis       Date:  2008-05-07       Impact factor: 2.571

9.  Neoadjuvant chemotherapy can improve outcome of colorectal cancer patients with unresectable metastasis.

Authors:  Yen-Chen Shao; Yu-Yao Chang; Jen-Kou Lin; Chun-Chi Lin; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Yuan-Tzu Lan; Tzu-Chen Lin; Anna Fen-Yau Li; Wei-Shone Chen; Shih-Ching Chang
Journal:  Int J Colorectal Dis       Date:  2013-05-22       Impact factor: 2.571

10.  Induction of apoptosis and cell cycle arrest in human colorectal carcinoma by Litchi seed extract.

Authors:  Chih-Ping Hsu; Chih-Cheng Lin; Chiu-Chen Huang; Yi-Hsien Lin; Jyh-Ching Chou; Yu-Ting Tsia; Jhih-Rou Su; Yuan-Chiang Chung
Journal:  J Biomed Biotechnol       Date:  2012-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.